Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Mutual Funds
Invest in Mutual Funds
Invest in direct mutual funds at zero charges via lump sump investments or SIPs
DSP Nifty Healthcare Index Fund Growth
NAV: 24 Sep '26
₹11.83
Min. for SIP
₹100
Fund size (AUM)
₹25.41 Cr
Expense ratio
1.08%
Rating
--
Return calculator
Monthly investment
₹5,000
| Over the past | Total investment | Would've become | Historic returns | Returns |
|---|---|---|---|---|
| 3 months | ₹15,000 | ₹15,131 | +0.87% | |
| 6 months | ₹30,000 | ₹31,706 | +5.69% | |
| 1 year | ₹60,000 | ₹65,900 | +9.83% |
Holdings (22)
| Name | Sector | Instruments | Assets |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 18.08% |
| Divi's Laboratories Ltd | Healthcare | Equity | 10.35% |
| Apollo Hospitals Enterprise Ltd | Healthcare | Equity | 7.88% |
| Cipla Ltd | Healthcare | Equity | 6.82% |
| Max Healthcare Institute Ltd | Healthcare | Equity | 6.67% |
| Laurus Labs Ltd | Healthcare | Equity | 6.41% |
| Torrent Pharmaceuticals Ltd | Healthcare | Equity | 6.39% |
| Dr. Reddy's Laboratories Ltd | Healthcare | Equity | 6.05% |
| Lupin Ltd | Healthcare | Equity | 4.57% |
| Aurobindo Pharma Ltd | Healthcare | Equity | 4.09% |
| Fortis Healthcare Ltd | Healthcare | Equity | 4.07% |
| Glenmark Pharmaceuticals Ltd | Healthcare | Equity | 3.21% |
| Alkem Laboratories Ltd | Healthcare | Equity | 2.68% |
| Biocon Ltd | Healthcare | Equity | 2.53% |
| Zydus Lifesciences Ltd | Healthcare | Equity | 2.50% |
| Ipca Laboratories Ltd | Healthcare | Equity | 2.36% |
| Mankind Pharma Ltd. | Healthcare | Equity | 2.36% |
| Abbott India Ltd | Healthcare | Equity | 1.15% |
| Piramal Pharma Ltd | Healthcare | Equity | 1.15% |
| Syngene International Ltd | Healthcare | Equity | 0.66% |
| Reverse Repo | Unspecified | Reverse Repo | 0.15% |
| Net Payables | Unspecified | Net Payables | -0.13% |
See All
Minimum investments
Min. for 1st investment
₹100
Min. for 2nd investment
₹100
Min. for SIP
₹100
Returns and rankings
Annualised returns
Absolute returns
| Name | 3M | 6M | 1Y | All |
|---|---|---|---|---|
| Fund returns | +5.1% | +17.6% | +14.6% | +18.3% |
| Category average (Equity Sectoral) | +6.9% | +23.2% | +18.0% | +484.9% |
| Rank (Equity Sectoral) | 26 | 29 | 22 | -- |
Exit load, stamp duty and tax
Exit load
Nil
Stamp duty on investment: 0.005% (from July 1st, 2020)
from July 1st 2020
Tax implication
If you redeem within one year, returns are taxed at 20%. If you redeem after one year, returns exceeding Rs 1.25 lakh in a financial year are taxed at 12.5%.
Check past data
Fund management
DSDiipesh ShahJun 2025 - PresentView details
DS
Diipesh Shah
Jun 2025 - Present
View details
AGAnil GhelaniJun 2025 - PresentView details
AG
Anil Ghelani
Jun 2025 - Present
View details
NRNeha RathiMay 2026 - PresentView details
NR
Neha Rathi
May 2026 - Present
View details
About DSP Nifty Healthcare Index Fund Growth
DSP Nifty Healthcare Index Fund Growth is a Equity Mutual Fund Scheme launched by DSP Mutual Fund. This scheme was made available to investors on 16 Dec 1996. Diipesh Shah is the Current Fund Manager of DSP Nifty Healthcare Index Fund Growth fund. The fund currently has an Asset Under Management(AUM) of ₹2,51,811 Cr and the Latest NAV as of 24 Sep 2026 is ₹11.83.
The DSP Nifty Healthcare Index Fund Growth is rated Very High risk. Minimum SIP Investment is set to ₹100. Minimum Lumpsum Investment is ₹100.
;
Investment Objective
The scheme seeks to generate returns that are commensurate with the performance of the Nifty Healthcare Index, subject to tracking error.
Fund benchmarkNIFTY Healthcare Total Return Index.
Fund house
Rank (total assets)#10 in India
Total AUM₹2,51,810.80 Cr
Date of Incorporation16 Dec 1996
Launch Date16 Dec 1996
AddressThe Ruby, 25th Floor29, Senapati Bapat Marg,Dadar (West), Mumbai Mumbai 400028
CustodianHongkong & Shanghai Banking Corporation
Registrar & Transfer AgentCams
Email[email protected]
Websitewww.camsonline.com
Address7th Floor, Tower II, Rayala Towers, 158, Anna Salai,